MTC News Briefs

Radiolabeled somatostatin analogs can be useful for the management of recurrent medullary thyroid carcinoma (MTC) after a thyroidectomy, according to a study. The results showed that gallium-68 dodecane tetraacetic acid tyr3-octreotate positron emission tomography-computed tomography (68Ga-DOTATAE PET-CT) had a relatively high detection rate, and peptide receptor radionuclide therapy with 177Lu-DOTATATE was a safe alternative for…

Sulfatinib and SPP86 show antitumor activity both in medullary thyroid carcinoma (MTC) cell lines and a zebrafish model of thyroid cancer, a recent study suggests. Sulfatinib is a multitarget kinase inhibitor selective for fibroblast growth factor receptor-1 (FGFR-1) and the vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, while SPP86 is a RET-specific…

Cervical lymph node metastases from medullary thyroid cancer (LNM-MTC) seemed to have sonographic features of fewer calcifications, lack of hilum, and larger size in comparison to the lymph node metastases from papillary thyroid cancer (LNM-PTC), a study suggests. The results showed similarities in long-axis diameter, short-axis diameters, gender, shape, cystic change, echogenicity, border, vascularity, and…